[{"Assets_0_Q2_USD":933986000.0,"CommonStockSharesOutstanding_0_Q2_shares":120404676.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-48249000.0,"NetIncomeLoss_1_Q2_USD":-18664000.0,"NetIncomeLoss_2_Q2_USD":-50063000.0,"StockholdersEquity_0_Q2_USD":550870000.0,"Ticker":"PGEN","CIK":"1356090","name":"INTREXON CORP","OfficialName":"Precigen Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337298902.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]